LifeMD (NASDAQ:LFMD) is scheduled to announce Q4 earnings results on Monday, March 10th, after market close. The consensus EPS Estimate is $0.14 (-6.7% Y/Y) and the consensus Revenue Estimate is ...

Eli Lilly partnered up with telehealth providers LifeMD and Teladoc Health to offer its lower cost, single-vial ...

We came across a bullish thesis on LifeMD, Inc. (LFMD) on Twitter by Cluseau Investments. In this article, we will summarize ...

As part of the deal, which will be completed later this year, the Chicago-based pharmacy chain will sell its VillageMD unit. Other pharmaceutical news is about Cost Plus Drug Co., Eli Lilly, and more.

LifeMD Inc (NASDAQ:LFMD) is set to release its Q4 2024 earnings on March 10, 2025. The consensus estimate for Q4 2024 revenue ...

Telehealth firms Teladoc and LifeMD said on Thursday they had signed an agreement to offer Eli Lilly's weight-loss drug ...

The partnership comes as telehealth companies grapple with restrictions on the sale of some compounded GLP-1s.

Teladoc Health (NYSE: TDOC) today announced a pharmacy integration agreement with Eli Lilly's LillyDirect pharmacy partner, Gifthealth, which will help ...

In a report released today, Brooks O’Neil from Lake Street maintained a Buy rating on LifeMD (LFMD – Research Report), with a price target of ...

LifeMD, a virtual primary care services provider, said it is integrating with Gifthealth which will make Lilly's single-dose vials of Zepbound accessible to the company's eligible patients.

LifeMD董事长兼首席执行官Justin Schreiber表示支持礼来公司让肥胖治疗更易获得的努力，并赞扬与Gifthealth的无缝整合为患者带来更好的体验。Schreiber强调LifeMD致力于以患者为中心、经济实惠且便捷的医疗保健服务，他认为这将使其体重管理项目能够帮助患者实现更健康的生活。

As the AetherLux heat pump system continues toward commercialization, Worksport remains committed to delivering on its own ...